Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

inhalational botulism - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

inhalational botulism

MONDO:0016777

Also known as:inhalation botulism

Overview

Inhalational botulism is a man-made form of botulism, a rare acquired neuromuscular junction disease with descending flaccid paralysis caused by botulinum neurotoxins (BoNTs).

ResearchLimited published research (7 articles)

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

Features include very common findings: Urinary retention, Xerostomia, Ptosis, and Diplopia and others; and common findings: Diarrhea, Nausea and vomiting, and Dyspnea.

Organ System	Phenotype Count	Example Features
Digestive system	3	Diarrhea, Nausea and vomiting, Constipation

Prognosis

Phenotype severity distribution: 10 very common features, 3 common features.

Estimated prevalence: <1 in 1,000,000 (VERY_RARE).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for inhalational botulism.

7 publications have been identified in PubMed for inhalational botulism. Research spans Review / Meta-Analysis (57%), Case Report / Case Series (29%), and Epidemiology / Natural History (14%).

Recent Publications

Jeffery IA (2026). [PMID: 29083673](https://pubmed.ncbi.nlm.nih.gov/29083673/). *Unknown Journal*. [Review / Meta-Analysis]
Kihara K (2026). [PMID: 42156031](https://pubmed.ncbi.nlm.nih.gov/42156031/). *Brain Nerve*. [Review / Meta-Analysis]
Shah K (2026). [PMID: 42232081](https://pubmed.ncbi.nlm.nih.gov/42232081/). *Front Bioeng Biotechnol*. [Review / Meta-Analysis]
Fraser B (2025). [PMID: 39805649](https://pubmed.ncbi.nlm.nih.gov/39805649/). *CMAJ*. [Review / Meta-Analysis]
Juillerat A (2024). [PMID: 39385561](https://pubmed.ncbi.nlm.nih.gov/39385561/). *Rev Med Suisse*. [Case Report / Case Series]
Horabi M (2024). [PMID: 39634626](https://pubmed.ncbi.nlm.nih.gov/39634626/). *New Microbes New Infect*. [Epidemiology / Natural History]

Data assembled from 4 of 12 sources · Last updated Sep 17, 2026, 9:20 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:254504

GARD

Genetic and Rare Diseases Info Center

GARD:20746

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

inhalational botulism

Overview

Clinical Presentation

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features